B. Metzler Seel. Sohn & Co. Holding Ag Charles River Laboratories International, Inc. Transaction History
B. Metzler Seel. Sohn & Co. Holding Ag
- $10.1 Trillion
- Q3 2024
A detailed history of B. Metzler Seel. Sohn & Co. Holding Ag transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, B. Metzler Seel. Sohn & Co. Holding Ag holds 1,126 shares of CRL stock, worth $188,357. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,126
Previous 2,189
48.56%
Holding current value
$188,357
Previous $903,000
24461.24%
% of portfolio
0.0%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding CRL
# of Institutions
710Shares Held
53.9MCall Options Held
122KPut Options Held
239K-
Vanguard Group Inc Valley Forge, PA6.16MShares$1.03 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$851 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA4.08MShares$682 Million0.14% of portfolio
-
State Street Corp Boston, MA2.18MShares$365 Million0.02% of portfolio
-
Allspring Global Investments Holdings, LLC1.81MShares$302 Million0.56% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $8.51B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...